Propanc Biopharma, Inc. (PPCB) AI Dilution Summary

Cash was $832,006 at 2026-06-30 against estimated monthly burn of $533,994. Since then, Series C Warrant exercises brought in $500,000 on 2026-08-04 and $1,500,000 on 2026-08-31, and a share buyback of $500,000 is dated 2026-08-31. Dilution here is driven primarily by the 200 shares of Series C Convertible Preferred ($2,000,000 aggregate liquidation preference as filed).